|
End-of-day quote
Shanghai S.E.
28/10/2026
|
5-day change | 1st Jan Change | ||
| 8.400 CNY | +3.70% |
|
-4.87% | -13.40% |
| 08-27 | Sinotherapeutics Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-29 | Sinotherapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 3.77B 566M 508M 469M 425M 794M 53.88B 804M 5.61B 2.23B 28.19B 2.12B 2.08B 89.5B | P/E 2024 |
35.9x | P/E 2025 | 88.2x |
|---|---|---|---|---|---|
| Enterprise Value | 3.03B 454M 407M 376M 341M 637M 43.21B 645M 4.5B 1.79B 22.61B 1.7B 1.67B 71.79B | EV / Sales 2024 |
7.4x | EV / Sales 2025 | 8.08x |
| Free-Float |
25.56% | Yield 2024 |
0.62% | Yield 2025 | 0.36% |
| 1 day | +3.70% | ||
| 1 week | -4.87% | ||
| Current month | -16.75% | ||
| 1 month | -14.98% | ||
| 3 months | -0.94% | ||
| 6 months | -8.30% | ||
| Current year | -13.40% |
| 1 week | 7.9 |  | 8.78 |
| 1 month | 7.9 | | 10.33 |
| Current year | 7.02 | | 11.33 |
| 1 year | 7.02 | | 11.46 |
| 3 years | 6.3 | | 14 |
| 5 years | 6.3 | | 28 |
| 10 years | 6.3 | | 28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Jie Guo
CEO | Chief Executive Officer | 53 | 06/04/2023 |
Yi Ming Wu
DFI | Director of Finance/CFO | 57 | 30/04/2025 |
Hui Zhang
IRC | Investor Relations Contact | 44 | 31/05/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Jun Ye
CHM | Chairman | 53 | 18/08/2020 |
Xiao Ming Ying
BRD | Director/Board Member | 58 | 01/08/2012 |
Si Yu Shen
BRD | Director/Board Member | 44 | 01/09/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.70% | -4.87% | -21.64% | -25.99% | 545M | |
| +0.50% | +1.38% | +57.09% | +127.73% | 1,143B | |
| +0.86% | +5.14% | +45.00% | +84.34% | 647B | |
| -0.14% | +0.42% | +25.69% | +101.56% | 506B | |
| -0.05% | +2.28% | +49.14% | +67.74% | 384B | |
| -0.63% | -5.97% | +61.93% | +37.25% | 350B | |
| +0.34% | +2.15% | +25.26% | +54.27% | 293B | |
| -0.45% | +1.16% | +1.74% | +26.08% | 265B | |
| +0.87% | +3.08% | +54.69% | +71.67% | 242B | |
| +0.08% | +3.67% | +35.05% | +104.71% | 197B | |
| Average | +0.84% | +0.75% | +33.39% | +64.94% | 402.81B | |
| Weighted average by Cap. | +0.79% | +0.71% | +43.67% | +87.34% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 512M 76.74M 68.85M 63.65M 57.65M 108M 7.31B 109M 761M 303M 3.82B 288M 282M 12.14B | 447M 66.98M 60.09M 55.56M 50.32M 94.01M 6.38B 95.15M 664M 265M 3.34B 251M 246M 10.6B |
| Net income | 128M 19.15M 17.18M 15.89M 14.39M 26.88M 1.82B 27.21M 190M 75.66M 955M 71.88M 70.36M 3.03B | 47.48M 7.12M 6.39M 5.91M 5.35M 10M 678M 10.12M 70.63M 28.13M 355M 26.73M 26.16M 1.13B |
| Net Debt | -734M -110M -98.71M -91.26M -82.65M -154M -10.48B -156M -1.09B -435M -5.48B -413M -404M -17.41B | -746M -112M -100M -92.87M -84.11M -157M -10.66B -159M -1.11B -442M -5.58B -420M -411M -17.71B |
Employees
319
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/10/26 | CN¥8.400 | +3.70% | 5,334,713 |
| 27/10/26 | CN¥8.100 | -5.59% | 4,459,328 |
| 26/10/26 | CN¥8.580 | +0.70% | 3,693,294 |
| 23/10/26 | CN¥8.520 | +1.31% | 5,748,739 |
| 22/10/26 | CN¥8.410 | -3.67% | 3,952,602 |
- Stock Market
- Stocks
- 688247 Stock
Select your edition
All financial news and data tailored to specific country editions
